|

Budesonide Clinical Trials

3 actively recruiting trials

Also known as: Pulmicort

Pipeline

Phase 3: 1Phase 4: 2

Top Sponsors

  • University of British Columbia1
  • Novartis Pharmaceuticals1
  • Maria Joyera Rodríguez1

Indications

  • Asthma2
  • Glucocorticoid Resistance1
  • Exposure to Pollution1
  • Chronic Obstructive Pulmonary Disease1
  • COPD1

Other3 trials

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Phase 3
Diesel Exhaust Induces Glucocorticoid Resistance
Phase 4
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.